Listeria-based booster improves vaccine's protection against recurring colon cancer



Listeria-based booster improves vaccine’s protection against recurring colon cancer

New research in mice has paved the way for a Phase I clinical trial and has the potential to transform vaccines against HIV and malaria.

Materials provided by Thomas Jefferson University. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

31st March 2023

Form is (mal)function: Protein's shape lets bacteria disarm it

Read more
30th March 2023

Researchers discover a way to fight the aging process and cancer development

Read more
30th March 2023

Researchers identify cell type that could be key to preventing marrow transplant complication

Read more